<- Go Home
CeriBell, Inc.
CeriBell, Inc. operates as a medical technology company in the United States. It develops the Ceribell System, a novel and point-of-care EEG platform specifically designed to address the unmet needs of patients in the acute care setting. The company also offers disposable, flexible headbands, and headcaps; and a pocket-sized, rechargeable battery-operated recorder used to capture and wirelessly transmit EEG signals; and Clarity, an AI-powered seizure detection algorithm. In addition, it operates an EEG portal, which enables real-time remote access to a patient’s EEG data. The company was formerly known as Brain Stethoscope, Inc. and changed its name to CeriBell, Inc. in August 2015. CeriBell, Inc. was incorporated in 2014 and is headquartered in Sunnyvale, California.
Market Cap
$635.5M
Volume
357.7K
Cash and Equivalents
$45.3M
EBITDA
-$63.7M
Tax Rate Collected
N/A
Tax Rate Ratio
N/A
Gross Profit
$83.4M
Profit Margin
87.72%
52 Week High
$24.33
52 Week Low
$10.85
Dividend
N/A
Price / Book Value
4.50
Price / Earnings
-10.26
Price / Tangible Book Value
4.50
Enterprise Value
$516.5M
Enterprise Value / EBITDA
-8.30
Operating Income
-$64.9M
Return on Equity
37.53%
Return on Assets
-20.73
Cash and Short Term Investments
$141.2M
Debt
$22.1M
Equity
$140.8M
Revenue
$95.1M
Unlevered FCF
-$28.5M
Sector
Health Care Equipment and Supplies
Category
N/A